Trial intelligence / Profile preview

Etoricoxib vs Ibuprofen for Third Molar Extraction Pain

NCT00855777Phase 4Unknown

Sponsor
Università degli Studi di Verona
Start
Apr 2009
Primary completion
Dec 2009
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial of etoricoxib in postoperative pain (2 arms), sponsored by Università degli Studi di Verona. Primary endpoint: Analgesic efficacy at 3 days. Status: unknown.

02

Drugs

etoricoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00855777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00855777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call